| Mary Elizabeth Rhodes, | |
|
249 E Tabernacle St Ste 100, St George, UT 84770-2951 | |
| (385) 275-6008 | |
| Not Available |
| Full Name | Mary Elizabeth Rhodes |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 249 E Tabernacle St Ste 100, St George, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720770738 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Elizabeth Rhodes, 2911 S Carriage Ln, Washington, UT 84780-2922 Ph: (919) 699-7026 | Mary Elizabeth Rhodes, 249 E Tabernacle St Ste 100, St George, UT 84770-2951 Ph: (385) 275-6008 |
News Archive
Further underscoring its ongoing commitment to lung health, Medtronic today unveiled a next-generation version of its superDimension navigation system software. The superDimension navigation system enables a minimally invasive approach to access difficult-to-reach areas of the lung, and can aid in the diagnosis of lung diseases.
Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce its new training simulator for pelvic floor repair, to be exhibited for the first time at the ACOG 59th Annual Clinical Meeting in Washington, DC, April 30- May 4, 2011.
At this year's Radiology Society of America (RSNA) annual meeting, GE Healthcare, a $17 billion unit of General Electric Company presented the new Innova® dose-efficient X-ray technology powered by the innovative GE AutoEx control system, which automatically and continuously adapts to help keep image quality and patient dose at optimum levels.
A large international study led by a Hamilton researcher has found a patient-centric treatment that works for people with mild asthma.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.
› Verified 4 days ago
Lukas Hildebrandt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St Ste 7, St George, UT 84770 Phone: 801-255-5131 | |
Jan Hadlock, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 | |
Andrew J Weibert, Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 N Bluff St Ste 5, St George, UT 84770 Phone: 435-229-9177 | |
Jason Reynolds, Counselor Medicare: Not Enrolled in Medicare Practice Location: 348 E 600 S, St George, UT 84770 Phone: 435-705-7574 | |
Sarah Cowley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 474 W 200 N, Suite 300, St George, UT 84770 Phone: 435-634-5621 Fax: 435-986-8700 | |
Kiley Shelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St, Suite 7, St George, UT 84770 Phone: 801-255-5131 Fax: 801-255-5131 | |
Samantha Montag, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 |